Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.

Abstract

PURPOSE Proteomic screening revealed declined levels of the receptor for advanced glycation end products (RAGE) in human idiopathic pulmonary fibrosis (IPF). This study was undertaken to investigate the different RAGE isoforms in two lung diseases with destruction of the lung parenchyma, i.e. IPF and chronic obstructive pulmonary disease (COPD… (More)
DOI: 10.1002/prca.200900128

5 Figures and Tables

Statistics

020406020112012201320142015201620172018
Citations per Year

73 Citations

Semantic Scholar estimates that this publication has 73 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ohlmeier2010ProteomicSO, title={Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.}, author={Steffen Ohlmeier and Witold Mazur and Kaisa M Salmenkivi and Marjukka Myll{\"a}rniemi and Ulrich Bergmann and Vuokko L. Kinnula}, journal={Proteomics. Clinical applications}, year={2010}, volume={4 1}, pages={97-105} }